FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Oslo University Hospital
Oslo, NoruegaPublicaciones en colaboración con investigadores/as de Oslo University Hospital (17)
2024
-
Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis
Immuno-Oncology and Technology, Vol. 21
2021
-
(Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder
Cancers, Vol. 13, Núm. 22
-
Treatment of Multisystem Inflammatory Syndrome in Children
New England Journal of Medicine, Vol. 385, Núm. 1, pp. 11-22
2019
-
A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma
Current Urology Reports, Vol. 20, Núm. 1
-
Effects of teriparatide on hip and upper limb fractures in patients with osteoporosis: A systematic review and meta-analysis
Bone, Vol. 120, pp. 1-8
-
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology
npj Precision Oncology, Vol. 3, Núm. 1
-
Precise immunodetection of PTEN protein in human neoplasia
Cold Spring Harbor Perspectives in Medicine, Vol. 9, Núm. 12
-
The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder
Human Pathology, Vol. 91, pp. 61-68
2018
-
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study (Intensive Care Medicine, (2016), 42, 12, (1865-1876), 10.1007/s00134-016-4571-5)
Intensive Care Medicine
-
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database
Critical Care, Vol. 22, Núm. 1
-
Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X-Ray–Based Bone Assessment Techniques
Journal of Bone and Mineral Research, Vol. 33, Núm. 12, pp. 2230-2235
2017
-
Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial
Journal of Bone and Mineral Research, Vol. 32, Núm. 5, pp. 1040-1051
-
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study
The Lancet Respiratory Medicine, Vol. 5, Núm. 8, pp. 627-638
2016
-
Effects of teriparatide compared with risedronate on recovery after pertrochanteric hip fracture results of a randomized, active-controlled, double-blind clinical trial at 26 weeks
Journal of Bone and Joint Surgery - American Volume, Vol. 98, Núm. 22, pp. 1868-1878
-
Effets du tériparatide et du risédronate sur la DMO et la consolidation fracturaire chez des patients âgés avec fracture pertrochantérique récente: Résultats finaux d'un essai clinique randomisé de 78 semaines
Revue du Rhumatisme (Edition Francaise), Vol. 83, pp. A83-A84
-
The expression of fibroblast activation protein in clear cell renal cell carcinomas is associated with synchronous lymph node metastases
PLoS ONE, Vol. 11, Núm. 12
2012
-
Molecular subclasses of breast cancer: How do we define them? The IMPAKT 2012 working group statement
Annals of Oncology, Vol. 23, Núm. 12, pp. 2997-3006